Amco India Limited Overview
Amco India Limited is a promoter-controlled, Delhi-NCR-based micro-cap converter of aluminium foil for flexible and pharmaceutical packaging. Although its legal and historical identity is rooted in PVC — the group began in 1981 with PVC leather cloth and added PVC calendered films and sheeting in 1991 — the company today is, in operational substance, a single-segment aluminium foil business: the PVC Films/Sheeting segment has generated nil revenue in both FY2025 and FY2026, while aluminium foil accounted for 100% of reported quarterly segment revenue throughout FY2026 and Q1 FY2027. The company rolls, anneals, coats, laminates, prints and slits foil at Noida (Uttar Pradesh) and Baddi (Himachal Pradesh), serving blister and strip packaging for Indian pharmaceutical companies (website customer references include Cipla, Hetero, Ajanta Pharma and USV), plus cigarette, milk-powder, pan masala, food-wrap and industrial applications. With revenue of ~INR 118 crore, sub-3% operating margins, no R&D, no exports and no institutional ownership, it is a price-taking niche processor trading below book value.
Sources: FY2026 Annual Report (Directors' Report, MD&A, dated 27 Aug 2026); BSE; company website; Screener.in; Emkay; MarketsMojo; Simply Wall St.
What the company does
Amco India manufactures and converts aluminium foil and foil laminates, and historically manufactured PVC leather cloth (coated fabric) and PVC calendered films and sheeting. According to the company's own product literature, the PVC leather cloth unit coats PVC onto fabric substrates in embossed and printed designs for furnishings, sports shoes and goods, belts and wallets; the PVC films and sheeting unit uses calendering to make material for shower curtains, automotive side door panels and sun visors, stationery, insulation tapes and rainwear. The aluminium foil operation supplies foil in thicknesses from 0.007 mm to 0.2 mm, plain, coated (e.g., VMCH heat-seal lacquer for blister lidding), laminated (with paper or LDPE) and gravure-printed up to multiple colours.
The FY2025 Annual Report's business overview (as summarised by Screener) describes the company as a manufacturer and seller of aluminium foil, PVC film/sheeting, PVC rigid, CCF (likely "cold-form/cold-compression foil" or coated fabric — the abbreviation is not expanded in the source), and non-woven fabrics/laminated fabrics. The FY2026 MD&A additionally references non-woven products using PP granules and pigments as raw materials, indicating at least a historical or residual non-woven line, though no revenue is attributed to it in segment reporting.
Company's own description (paraphrased from FY2026 Annual Report and website)
The company presents itself as a reliable domestic supplier of aluminium foil with a particular focus on pharmaceutical packaging. Management states that it has executed orders for packaging, pharmaceutical and automobile industries; that it now supplies leading players with foil for cigarette packaging, milk-powder packaging and medical/surgical equipment packaging; and that it has positioned itself to benefit from substitution of alternative substrates by foil in products such as gutkha and pan masala. Management's stated intent is to consolidate its position in pharma packaging and to enhance capacity in foil production and coating operations. The website describes the foil range as delivering barrier protection against moisture, light, oxygen and contaminants for packaging, pharmaceuticals, food and beverage, insulation and industrial uses.
Business model and revenue model
| Dimension | Characterisation |
|---|---|
| Revenue model | ~100% product sales (manufactured and converted foil). No subscription, licensing or service revenue disclosed. |
| Pricing | Conversion-margin model: aluminium (primary metal / foil stock) cost largely passed through; margin earned on rolling, annealing, coating, lamination, printing and slitting. Pricing tied to LME-linked aluminium prices and INR/USD; no pricing disclosures. |
| Order pattern | B2B, order-driven (management uses the phrase "executed orders"); likely a mix of rate contracts with pharma companies and spot business with converters/traders. Not disclosed. |
| Value chain position | Mid-stream converter: buys aluminium (foil stock or re-roll stock) from primary producers or traders → rolls/anneals/coats/laminates/prints → sells to pharma packers, converters, FMCG/tobacco packers and industrial users. Not integrated upstream into smelting or downstream into finished packs. |
| Customer types | Pharmaceutical manufacturers (blister and strip packs), flexible packaging converters, tobacco/pan masala packers, dairy (milk powder), medical device packers, automotive/industrial (heat-exchanger fins, cable wrap), trading houses. |
| End-markets | Pharmaceuticals (core), packaged food & dairy, tobacco/confectionery, medical devices, electrical/cable, HVAC (fins), automotive. |
| Geography | Effectively 100% domestic India: foreign exchange earnings were INR 0 in FY2026 and INR 23.96 lakh in FY2025. |
Independent characterisation
Amco India's identity in data feeds ("PVC leather cloth and aluminium foils"; BSE industry "Plastics – Sheets/Films") lags its economic reality. The PVC business is dormant — PVC segment revenue was INR ~16.4 lakh in FY2024 and nil in FY2025 and FY2026, while PVC capital employed is static at INR 2.83 crore. The company is a small, low-margin aluminium foil converter whose revenue base (~INR 118–124 crore) is heavily driven by metal prices rather than value-added volume. Its operating profit before other income has been between INR 1.2 crore and INR 2.8 crore in each of the last three fiscal years, so non-operating "other income" (INR 1.5–2.1 crore per year) has been comparable to, or larger than, core operating profit — a structural feature that makes reported earnings fragile. Its strategic levers are narrow: capacity utilisation, product mix (printed/coated pharma foil versus plain foil), working-capital discipline and procurement timing. A real-estate side venture (the "Krish Icons" association of persons in Bhiwadi, Rajasthan, 40% profit share) adds diversification of uncertain materiality.
Sources: FY2026 MD&A and Directors' Report; FY2025 Annual Report (via Screener key points); company website products and infrastructure pages; Simply Wall St; ROIC.ai company description.
Strategy
Stated strategy (themes from FY2026 Annual Report, paraphrased)
| Theme | Management articulation (paraphrased) | Evidence of execution |
|---|---|---|
| Pharma packaging focus | Consolidate position as a reliable supplier to pharma packaging; foresees domestic and international pharma demand growth | Pharma customers on website; blister/strip foil flagship; exports nil |
| Capacity enhancement | Working towards enhancing capacity in foil production and coating | Net fixed assets declining; FY2026 derived capex ~nil; no capex quantum or timeline disclosed |
| Product diversification / value-add | Shift to higher value-added products; new applications (cigarette, milk powder, medical/surgical, pan masala) | Mix data not disclosed; Q1 FY2027 margin improvement may reflect mix |
| New markets | Initiatives to enter new markets across both segments; website states plan to enter international markets | Forex earnings fell to nil in FY2026 |
| Operational efficiency & technology | Adopt advanced technologies, improve efficiencies, energy-efficient motors and LED lighting | Capital investment in energy-efficient equipment (amount not disclosed) |
| Risk mitigation | Strategic sourcing, efficiency, value-added segments to counter raw-material volatility and competition | — |
| Diversification (real estate) | AOP "Krish Icons" with Krish Infrastructures Pvt Ltd for housing in Bhiwadi; 40:60 profit share; units being sold | Disclosed under "Joint Ventures" in FY2026 Directors' Report; financial contribution not quantified |
| PVC segment | Management describes PVC market growth opportunities but discloses no revival plan | PVC revenue nil for two years |
Initiatives in the last 24 months
| Initiative | Date | Detail |
|---|---|---|
| Governance refresh | Jun 2024 | CMD appointment; new independent director |
| Audit architecture | Aug 2025 | 5-year secretarial auditor; cost auditor; new AoA conforming to Companies Act 2013 |
| Registered office relocation | Nov 2025 | Move from Rexine Bazaar to New Friends Colony, New Delhi |
| Internal audit | Feb 2026 | Sumit R Kumar & Co. appointed |
| Board strengthening | Aug 2026 | Third independent director (Neeraj Gupta) |
| Energy conservation | FY2026 | Energy-efficient motors, LEDs; solar street lighting being planned |
| Physical-share window | Dec 2025 | Regulatory special window for re-lodgement of transfer requests |
Medium-term targets / guidance
None. Amco India publishes no quantitative revenue, margin, capex or return targets and holds no earnings calls or investor days. Management's qualitative outlook in the FY2026 Directors' Report expresses confidence in strengthening its competitive position; the MD&A notes the company needs additional funds for working capital and long-term capital to support capacity and sales growth.
Sources: FY2026 Directors' Report and MD&A; company website.
Products & Services
Pricing models for individual products are not publicly disclosed; Amco India does not publish price lists. Launch years are not disclosed except where noted.
Aluminium Foil segment
| Product | Description & key specifications | Target customers / applications | Notes |
|---|---|---|---|
| Blister foil (lidding) | 0.02–0.025 mm hard-temper foil, VMCH heat-seal lacquer coated; plain or printed up to 4 colours | Pharma blister packs (tablet/capsule push-through lidding) | Website lists "Blister Foil" as flagship; described as accepted by leading pharma companies |
| Pharma strip foil | 0.03–0.04 mm soft foil laminated with 150-gauge LDPE | Pharma strip packs (sachet-style unit dose) | Flagship pharma product |
| Cigarette / label foil | 0.007 mm foil laminated with paper | Cigarette inner liners, labels | Company cites supply to "big" cigarette packers since FY2023 |
| Tea-chest lining / ORS substrate | 0.008–0.009 mm plain foil | Tea chests; oral rehydration salt sachet substrate | — |
| Label / lamination foil | 0.008–0.009 mm laminated with paper | Labels, lamination | — |
| Cheese wrap / lamination foil | 0.012 mm plain | Cheese wrapping; converter laminations | — |
| Household foil | 0.012/0.014/0.015 mm | Food wrapping | — |
| Soft bare foil | 0.05/0.064/0.075/0.09 mm, soft temper | Tagger foil, cable wrap, casseroles/containers | — |
| Fin stock | 0.12/0.16/0.20 mm | Fins for heat exchangers (HVAC, automotive radiators) | — |
| Cable wrap (Al-Mylar) | 0.20 mm bare | Cable shielding wrap | — |
| Milk-powder packaging foil | Laminated foil structures (spec not disclosed) | Dairy (milk powder) | Cited in FY2026 MD&A as a newer application |
| Medical/surgical equipment packaging foil | Laminated/coated foil (spec not disclosed) | Medical device packers | Cited in FY2026 MD&A |
| Pan masala / gutkha foil | Laminated foil (spec not disclosed) | Mouth-freshener/tobacco packers | MD&A cites substitution trend |
| Printed foil | Gravure printed on 6-colour, 4+3-colour (2 lines) and 2-colour lines at Baddi | Branded pharma and FMCG packs | Baddi capacity 100+ tonnes/month printed foil |
| BOPP foil / structures | Biaxially oriented polypropylene-based product listed on website | Flexible packaging | Whether manufactured, laminated or traded is not specified |
| CPP foil / structures | Cast polypropylene-based product listed on website | Flexible packaging heat-seal layers | As above |
| Glassine paper | Supercalendered, grease-resistant paper | Release liners, food/pharma interleaving | Website capacity 20+ tonnes/month |
| Kaneka Gemlac resins | Resin product branded "Kaneka Gemlac" listed on the website | Not described (likely coating/lacquer or PVC-related resin) | Nature of relationship with Kaneka (Japan) is not disclosed; likely traded/distributed product. No partnership disclosed in filings |
Process capability (Noida): cold rolling mill; in-built beta-gauge thickness controller (radioisotope source: Curium-244, 18.5 GBq / 500 mCi) for uniform gauge; Junker annealing oven with automatic time-temperature control; two lamination machines; two coating machines. Baddi: gravure printing (6-colour single line; 4+3-colour two lines; 2-colour single line), two double-shaft centre-winding slitters with auto-tension and edge guide, two doctoring machines, two core cutters; QC lab with analytical balance (GSM), bursting-strength, seal-strength, pinhole testing, viscosity cup, bond/heat-seal strength testers.
PVC Film/Sheeting segment (dormant)
| Product | Description | Applications | Status |
|---|---|---|---|
| PVC leather cloth (coated fabric) | PVC coated on fabric substrates; embossed and printed designs | Furnishings, sports shoes/goods, belts, wallets; historically automotive | No revenue disclosed FY2025–FY2026 |
| PVC calendered films & sheeting | Flexible PVC film via calendering (1991 line) | Shower curtains, auto side door panels/sun visors, stationery, insulation tapes, rainwear, table covers, suit covers | Nil revenue FY2025, FY2026 |
| PVC rigid | Rigid PVC film (referenced in FY2025 AR business overview) | Likely pharma blister forming film/stationery | Not reported separately |
| Non-woven fabrics / laminated fabrics | PP-based non-woven (raw materials PP granules and pigments) | Not specified | Referenced in FY2025 AR and FY2026 MD&A; no segment revenue |
Sources: company website (products, infrastructure, home pages); FY2026 MD&A; FY2025 Annual Report key points via Screener; ROIC.ai description.
Financial Narrative
Basis: Standalone, Ind AS, INR crore. FY2024–FY2026 rebuilt from Screener quarterly data and reconciled to audited PBT/PAT (Directors' Report FY2026: PBT INR 51.22 lakh FY2026, INR 228.37 lakh FY2025; PAT INR 33.10 lakh and INR 187.45 lakh). FY2022–FY2023 from Screener annual data (rounded to INR 1 crore; PAT derived from EPS × 41.10 lakh shares). FY2021 shown in prose for CAGR purposes (revenue ~INR 88 crore; PAT ~INR 1.47 crore).
Income statement
Gross profit: not disclosed on a consistent annual basis. S&P data (Simply Wall St) shows TTM to 31 Dec 2025 gross profit of INR 10.26 crore on revenue of ~INR 110 crore (gross margin ~9.1%, defined as revenue less cost of materials). EBIT ("operating income" in US terms) = EBITDA incl. other income less D&A: FY2024 2.24, FY2025 3.47, FY2026 1.56. Diluted EPS equals basic (no dilutive instruments). FY2022 PBT derived from 29% tax rate; FY2023 PBT from 35% tax rate (Screener). The FY2026 Screener annual row shows OPM 1.7%, which does not reconcile with its own quarterly data (1.0%); the quarterly-reconciled figure is used.
Revenue CAGR: FY2021→FY2026 (5-year): +6.0% (INR 88 crore → INR 117.76 crore; Screener reports 5.91%). FY2022→FY2026 (4-year): -6.8%. FY2023→FY2026 (3-year): -8.7% (Screener: -9%). PAT CAGR FY2021→FY2026: approximately -26% (INR 1.47 crore → INR 0.33 crore).
Company-reported FY2026 MD&A ratios (note definitional differences): Operating profit margin ratio -1.26% (FY2025: -1.79%) — the company's definition evidently excludes other income and deducts finance and depreciation charges, producing negative values; Net profit ratio 0.29% (FY2025: 1.79%).
Commentary — income statement.
-
The FY2022 spike and FY2024 collapse are price and mix effects, not franchise changes. Revenue rose 77% in FY2022 (to INR 156 crore) as aluminium prices surged post-pandemic and PVC still contributed; FY2024 revenue fell 33% as aluminium prices normalised and PVC revenue disappeared (INR ~16 lakh). Operating margin peaked at 4.1% in FY2022 — inventory gains in a rising-metal environment are a likely contributor — and has not exceeded 3% since.
-
Other income is structurally large relative to operations. In FY2024 other income (INR 2.10 crore) was 1.7× operating profit; in FY2026 (INR 1.50 crore) 1.3×. The nature of other income (interest on deposits/advances, real-estate AOP share, scrap, rentals) is not itemised in the sources accessed. Screener flags that "earnings include an other income of INR 1.50 crore." Without it, FY2026 would have been loss-making at PBT level.
-
FY2026: revenue up 11.8%, profit down 82%. Management attributes the decline to lower EBIT; MD&A and the Directors' Report cite intense competition and raw-material price volatility, and state that rupee movements significantly affected foil sales. Q1 FY2026 was loss-making (PBT -INR 0.14 crore at 0.27% OPM) and Q4 FY2026 OPM was 0.38%.
-
Q1 FY2027 inflection. Revenue INR 32.18 crore (+23.5% YoY), OPM 4.44% (highest in the 13-quarter series), PAT INR 0.94 crore — already ~2.8× FY2026's full-year PAT. One quarter does not establish a trend, particularly given the company's history of single strong quarters (e.g., Q3 FY2025 OPM 3.82% followed by Q4 FY2025 at 0.29%).
Quarterly series
Source: Screener.in quarterly results (C-MOTS), cross-checked to Capital Market/JM Financial (Q1 FY2027: sales 32.18, OPM 4.44%, PBDT 1.54, PBT 1.27, NP 0.94) and company filings (Q1 FY2027 revenue INR 3,217.92 lakh; PBT INR 127.49 lakh; PAT INR 94.34 lakh; company-reported EPS INR 2.30 vs Screener 2.29 — rounding). Q4 FY2025 tax rate of -105.88% reflects a deferred tax credit.
TTM (Q2 FY2026–Q1 FY2027): Revenue INR 123.89 crore; operating profit INR 2.52 crore (2.0%); other income INR 1.50 crore; PBT INR 1.92 crore; PAT INR 1.40 crore; EPS INR 3.40.
Balance sheet
Source: Screener balance sheet (rounded). Book value per share INR 92.1 (Screener, 31 Mar 2026) implies net worth of ~INR 37.9 crore. Company-reported debt/equity 0.34 (FY2026 and FY2025) is consistent with ~INR 13 crore of borrowings.
Commentary — balance sheet. The balance sheet is small and conservatively levered, with net worth compounding slowly (INR 34 crore → INR 38 crore over four years) because profits are thin and retained in full. Borrowings fell from INR 17 crore (FY2022) to INR 10 crore (FY2024) as revenue (and thus working capital) shrank, then rose to INR 13 crore in FY2025 as receivables and inventory days lengthened. "Other liabilities" jumped from INR 8 crore to INR 13 crore in FY2026 and "other assets" from INR 40 crore to INR 47 crore — consistent with higher payables and inventory (inventory days 67 vs 56; payable days 30 vs 18). Total capital employed was INR 41.99 crore at 30 June 2026. Fixed assets are declining in net terms (INR 18 crore → INR 15 crore), implying capex below depreciation — at odds with management's stated intent to enhance foil and coating capacity.
Cash flow
Source: Screener cash flow (rounded to INR 1 crore). Capex derived as CFO minus FCF. Positive investing inflows in FY2025–FY2026 suggest asset sales, deposit maturities or receipts from the Krish Icons AOP; not itemised in sources accessed.
Commentary — cash flow. Operating cash flow is dominated by working-capital swings in a metal-price-driven business: it was strongly positive in FY2024 (INR 7 crore) when revenue fell and working capital released, used to repay INR 6 crore of debt, and negative in FY2025–FY2026 as the cash conversion cycle lengthened from 71 to 99 days and then 90 days. Cumulative five-year FCF is approximately +INR 1 crore — essentially zero. The company has paid no dividend in at least 12 years (Screener: dividend payout 0% FY2015–FY2026) and has never bought back shares.
Ratios
Computed/6.3 data; FY2022–FY2023 computations use rounded inputs and are approximate. Working-capital days from Screener. ROIC: approximated by Screener ROCE (pre-tax); post-tax ROIC ≈ ROCE × (1 – tax rate), e.g., FY2026 ≈ 3%. Company-reported FY2026 MD&A ratios differ in definition: interest coverage 2.07 (FY2025: 4.14), ROE 0.88% (5.13%), return on net worth 4.14% (9.26%), current ratio 1.75 (1.95), debtor turnover 6.84 (6.85), inventory turnover 7.01 (8.66), debt/equity 0.34 (0.34). The company's "return on net worth" appears to be an EBIT-based measure.
Commentary — ratios. Returns have been below any reasonable cost of equity (Indian micro-cap cost of equity plausibly 14–16%) in every year except FY2022; Screener reports a 3-year average ROE of ~2.7% and 10-year ROE of ~4%. Leverage is modest in balance-sheet terms (D/E 0.34) but meaningful relative to earnings (gross debt/EBITDA ~4.9× in FY2026; interest coverage on the company's own measure halved from 4.14× to 2.07×). The lengthening cash conversion cycle (57 → 90–99 days) is the most important operating deterioration: on FY2026 revenue, each 10 days of CCC ties up ~INR 3.2 crore — roughly 10× FY2026 PAT.
Sources: Screener.in (P&L, balance sheet, cash flows, ratios, quarterly results); FY2026 Directors' Report (financial summary); FY2026 MD&A (key ratios); Simply Wall St (gross profit TTM); JM Financial/Capital Market (Q1 FY2027).
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | Contents | Products / services | Status |
|---|---|---|---|
Aluminium Foil | Rolling & conversion (Noida) and printing/lamination (Baddi) | Blister lidding foil, pharma strip foil, cigarette/label foil, tea-chest lining, cheese wrap, household foil, heat-exchanger fin stock, cable wrap, printed foil, foil-paper and foil-poly laminates; glassine paper; BOPP/CPP-based structures | Active — 100% of reported quarterly segment revenue in FY2026 and Q1 FY2027 |
PVC Film/Sheeting | Calendered PVC films and sheeting; historically also PVC leather cloth (coated fabric) | Shower curtain, auto interior, stationery, insulation tape, rainwear film; PVC leather cloth | Dormant — nil revenue FY2025, FY2026, Q1 FY2027; capital employed INR 282.51 lakh unchanged |
Revenue by Segment
| Segment / line (INR Cr) | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Aluminium Foil revenue (MD&A basis) | 89.60 | 96.67 | 110.14 |
PVC Film/Sheeting revenue (MD&A basis) | 0.16 | 0 | 0 |
Reconciling difference to revenue from operations | 13.83 | 8.63 | 7.62 |
Total revenue from operations | 103.59 | 105.30 | 117.76 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansSegment contribution & growth (%)
| Segment contribution & growth (%) | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Aluminium Foil share of revenue from operations (MD&A basis) | 86.5 | 91.8 | 93.5 |
PVC share of revenue from operations | 0.2 | 0 | 0 |
Aluminium Foil YoY growth (MD&A basis) | -14.7 | 7.9 | 13.9 |
Total revenue from operations YoY growth | -32.7 | 1.7 | 11.8 |
Results by Segment
| Aluminium Foil segment result (INR Lakh) | Q3 FY2025 | Q1 FY2026 | Q2 FY2026 | Q3 FY2026 | Q4 FY2026 | Q1 FY2027 |
|---|---|---|---|---|---|---|
Segment result | 81.69 | -19.30 | 26.62 | 17.68 | -18.09 | 116.42 |
Revenue by Segment (30 Jun 2025–30 Jun 2026)
| Capital employed (INR Lakh) | 30 Jun 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|
Aluminium Foil | 3,767.96 | 3,788.77 | 3,916.26 |
PVC Film/Sheeting | 282.51 | 282.51 | 282.51 |
Total | 4,050.47 | 4,071.28 | 4,198.77 |
Income Statement and Per-Share Data
| Metric (INR Cr) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue from operations | 156 | 154 | 103.59 | 105.30 | 117.76 |
Operating expenses | 150 | 152 | 102.35 | 102.54 | 116.60 |
Operating profit (EBITDA excl. other income) | 6 | 2 | 1.24 | 2.76 | 1.16 |
Other income | 2 | 1 | 2.10 | 1.92 | 1.50 |
EBITDA incl. other income | 8 | 3 | 3.34 | 4.68 | 2.66 |
Depreciation & amortisation | 1 | 1 | 1.10 | 1.21 | 1.10 |
Finance costs | 1 | 1 | 1.13 | 1.19 | 1.05 |
Profit before tax | 5.70 | 0.88 | 1.11 | 2.28 | 0.51 |
Net profit (PAT) | 4.05 | 0.57 | 0.83 | 1.87 | 0.33 |
EPS basic & diluted (INR) | 9.85 | 1.39 | 2.02 | 4.55 | 0.80 |
Dividend per share (INR) | 0 | 0 | 0 | 0 | 0 |
Margin & growth (%)
| Margin & growth (%) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Operating (EBITDA excl. OI) margin | 4.1 | 1.2 | 1.2 | 2.6 | 1.0 |
EBITDA margin incl. other income | 5.1 | 1.9 | 3.2 | 4.4 | 2.3 |
EBIT margin | 4.5 | 1.3 | 2.2 | 3.3 | 1.3 |
PBT margin | 3.7 | 0.6 | 1.1 | 2.2 | 0.4 |
Net margin | 2.6 | 0.4 | 0.8 | 1.8 | 0.3 |
Revenue growth YoY | 77.3 | -1.3 | -32.7 | 1.7 | 11.8 |
Effective tax rate | 29 | 35 | 25 | 18 | 35 |
Income Statement and Margin Analysis (%)
| Metric (INR Cr) | Q1FY24 | Q2FY24 | Q3FY24 | Q4FY24 | Q1FY25 | Q2FY25 | Q3FY25 | Q4FY25 | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 29.50 | 25.64 | 28.47 | 19.98 | 23.45 | 28.80 | 28.54 | 24.51 | 26.05 | 34.07 | 28.53 | 29.11 | 32.18 |
Operating profit | 0.33 | 0.37 | 0.29 | 0.25 | 0.80 | 0.80 | 1.09 | 0.07 | 0.07 | 0.53 | 0.45 | 0.11 | 1.43 |
OPM (%) | 1.12 | 1.44 | 1.02 | 1.25 | 3.41 | 2.78 | 3.82 | 0.29 | 0.27 | 1.56 | 1.58 | 0.38 | 4.44 |
Other income | 0.30 | 0.91 | 0.30 | 0.59 | 0.36 | 0.34 | 0.39 | 0.83 | 0.31 | 0.29 | 0.29 | 0.61 | 0.31 |
PBT | 0.07 | 0.73 | 0.00 | 0.31 | 0.63 | 0.57 | 0.91 | 0.17 | -0.14 | 0.31 | 0.21 | 0.13 | 1.27 |
Net profit | 0.05 | 0.53 | 0.00 | 0.25 | 0.47 | 0.40 | 0.66 | 0.35 | -0.14 | 0.26 | 0.15 | 0.05 | 0.94 |
EPS (INR) | 0.12 | 1.29 | 0.00 | 0.61 | 1.14 | 0.97 | 1.61 | 0.85 | -0.34 | 0.63 | 0.36 | 0.12 | 2.29 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansBalance Sheet
| Metric (INR Cr, 31 March) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Equity share capital | 4.11 | 4.11 | 4.11 | 4.11 | 4.11 |
Reserves & surplus | 30 | 31 | 32 | 33 | 34 |
Total equity (net worth) | 34 | 35 | 36 | 37 | 38 |
Total borrowings | 17 | 15 | 10 | 13 | 13 |
Other liabilities | 10 | 8 | 7 | 8 | 13 |
Total liabilities & equity | 61 | 58 | 52 | 58 | 64 |
Net fixed assets | 18 | 17 | 18 | 16 | 15 |
Capital work-in-progress | 0 | 1 | 1 | 1 | 1 |
Investments | 0 | 0 | 0 | 0 | 0 |
Other assets (current & non-current) | 43 | 40 | 33 | 40 | 47 |
Total assets | 61 | 58 | 52 | 58 | 64 |
Cash Flow and Margin Analysis (%)
| Metric (INR Cr) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Cash from operating activities | -1 | 3 | 7 | -4 | -1 |
Capital expenditure (derived) | 1 | 1 | 2 | 1 | 0 |
Free cash flow | -2 | 2 | 5 | -3 | -1 |
Cash from investing activities | 0 | 0 | 0 | 2 | 1 |
Cash from financing activities | 0 | -3 | -6 | 2 | -1 |
Dividends paid | 0 | 0 | 0 | 0 | 0 |
Share buybacks | 0 | 0 | 0 | 0 | 0 |
CFO / operating profit (%) | -1 | 252 | 546 | -120 | -9 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE (%) (PAT / closing equity) | 11.9 | 1.6 | 2.3 | 5.1 | 0.9 |
ROA (%) (PAT / total assets) | 6.6 | 1.0 | 1.6 | 3.2 | 0.5 |
ROCE (%) (Screener) | 14 | 4 | 3 | 8 | 5 |
Debt / equity (x) | 0.50 | 0.43 | 0.28 | 0.35 | 0.34 |
Gross debt / EBITDA incl. OI (x) | 2.1 | 5.0 | 3.0 | 2.8 | 4.9 |
Interest coverage (EBIT / interest) (x) | 6.7 | 1.9 | 2.0 | 2.9 | 1.5 |
Asset turnover (x) (revenue / total assets) | 2.56 | 2.66 | 1.99 | 1.82 | 1.84 |
Debtor days | 30 | 35 | 47 | 60 | 53 |
Inventory days | 46 | 38 | 40 | 56 | 67 |
Payable days | 15 | 15 | 16 | 18 | 30 |
Cash conversion cycle (days) | 61 | 57 | 71 | 99 | 90 |
Revenue by Region
| Region (INR Cr) | FY2025 | FY2026 |
|---|---|---|
Export revenue (foreign exchange earnings) | 0.24 | 0 |
Domestic revenue (India, derived) | 105.06 | 117.76 |
Foreign exchange outgo | 0.06 | 0.01 |
Growth (%)
| Growth (%) | FY2026 YoY |
|---|---|
Domestic | 12.1 |
Export | -100 |
Valuation Snapshot
| Metric | Value | Source / date |
|---|---|---|
Last price | INR 66.73 | IIFL, 16 Oct 2026 |
52-week high / low | INR 105 (≈ INR 104.99) / INR 56.5 | Screener; Aaj Tak (Aug 2026) |
Shares outstanding | 41,10,000 | FY2026 Directors' Report |
Market capitalisation | ~INR 27.4 crore | Computed |
Face value | INR 10 | — |
Typical daily volume | Hundreds to low thousands of shares (e.g., 91–3,367 shares on sampled days, Jul–Aug 2026) | Trendlyne; Aaj Tak |
Weekly volatility | ~8% (higher than 75% of Indian stocks) | Simply Wall St |
Price return (%) | Value | — |
1 year | -19 | — |
3-year CAGR | 4 | — |
5-year CAGR | 7 | — |
10-year CAGR | 13 | — |
Valuation Multiples
| Multiple | Amco India (TTM to Jun 2026) | Note |
|---|---|---|
P/E | 19.6× | On TTM EPS INR 3.40; on FY2026 EPS INR 0.80 the P/E is ~83× |
P/B | 0.72× | BVPS INR 92.1 (31 Mar 2026) |
EV/Sales | 0.33× | EV ≈ INR 40.4 crore (market cap INR 27.4 crore + debt INR 13 crore; cash assumed negligible — not disclosed) |
EV/EBITDA (incl. other income) | 10.1× | TTM EBITDA incl. OI INR 4.02 crore |
EV/EBITDA (excl. other income) | 16.0× | TTM operating profit INR 2.52 crore |
Dividend yield | 0% | — |
Capital Markets
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Dividend per share (INR) | 0 | 0 | 0 | 0 | 0 |
Payout ratio (%) | 0 | 0 | 0 | 0 | 0 |
Analyst Conclusions
Management guidance
No quantitative guidance. Qualitative: management expects domestic foil demand to strengthen on pharma capacity expansion and packaging trends, intends to enhance foil and coating capacity, and is pursuing value-added products and new markets; it acknowledges intense competition, raw-material volatility and the need for additional funding.
Consensus expectations
None (no coverage). Analyst framing: if Q1 FY2027 run-rates were sustained (revenue ~INR 32 crore/quarter; OPM ~4%), FY2027 revenue could approach ~INR 125–130 crore and PAT ~INR 3–4 crore (EPS ~INR 7–9). This is an illustrative scenario, not a forecast; Amco's quarterly history (e.g., Q3 FY2025 OPM 3.82% followed by Q4 FY2025 0.29%) argues strongly against extrapolating a single quarter.
Bull case
-
Operating leverage is real. Q1 FY2027 showed that +23.5% revenue lifted OPM from 0.27% to 4.44% and turned a loss into INR 0.94 crore of PAT — ~2.8× FY2026's full-year profit — demonstrating the earnings sensitivity of a low-fixed-cost converter.
-
Asset backing limits downside. At 0.72× book (BVPS INR 92.1) with D/E of 0.34, the market values the company below the equity on its balance sheet; foil capital employed alone is INR 39.2 crore vs market cap of INR 27.4 crore.
-
Structural demand tailwinds. India foil packaging (~USD 1.43 billion, ~5.8% CAGR) and pharma (~USD 60 billion → ~USD 130 billion by 2030) are expanding, and plastic-to-foil substitution supports volumes; foil revenue grew 14% in FY2026 on the company's MD&A basis.
Bear case
-
No durable margin. OPM has not exceeded 4.4% in 13 quarters and averaged ~1.6% over FY2024–FY2026; FY2026's foil segment essentially broke even (~INR 6.9 lakh), with PBT reliant on other income.
-
Cash and capital allocation do not compound value. Five-year cumulative FCF ≈ INR 1 crore; ROE averaged ~2.7% over three years; PVC capital idle; real-estate AOP outside core competence; CMD pay exceeded FY2026 PAT; no dividends in 12+ years.
-
Governance and liquidity discounts are justified. Unresolved BSE SOP fines and promoter demat freeze, combined Chair/MD, promoter on the Audit Committee, zero institutional ownership, no analyst coverage, and trading volumes of a few hundred shares a day make price discovery unreliable (e.g., +20% in one day, fully reversed within three months).
Catalysts and monitorables (next 12 months)
| Catalyst / monitorable | Expected timing | What to watch |
|---|---|---|
| Q2 FY2027 results | By mid-Nov 2026 | Whether OPM holds above ~3% and revenue above ~INR 30 crore |
| Q3 FY2027 results | By mid-Feb 2027 | Consistency; working-capital trend |
| FY2027 audited results | By end-May 2027 | Full-year PAT vs ~INR 0.33 crore base; CFO turning positive |
| BSE decision on SOP-fine waiver | Uncertain | Resolution of promoter demat freeze |
| Capacity enhancement announcement | Uncertain | Quantum, funding (debt vs equity), timeline |
| PVC segment decision | Uncertain | Revival, sale or write-off of INR 2.83 crore capital employed |
| Krish Icons AOP | Ongoing | Profit share recognition and cash repatriation |
| Statutory auditor rotation | 40th AGM (2027) | V. V. Kale & Co. term ends; new auditor appointment |
| Aluminium price and INR/USD | Continuous | Inventory gains/losses; pass-through lags |
| Regulatory changes in tobacco/pan masala packaging | Continuous | Demand risk for new applications |
Analyst verdict
Amco India Limited is best understood not as the "PVC leather cloth and aluminium foil" company its data-feed descriptions suggest, but as a single-product, sub-scale aluminium foil converter with a dormant PVC legacy and a small real-estate side interest. Its foil franchise is genuine — four decades of operating history, a full conversion chain across Noida and Baddi, and references among recognised Indian pharmaceutical companies — and its balance sheet is unencumbered by heavy debt. Those attributes explain why the stock trades on asset value (0.72× book) rather than collapsing on earnings.
The problem is economic, not existential. Over FY2024–FY2026 the company converted roughly INR 327 crore of cumulative revenue into about INR 5.2 crore of operating profit and INR 3.0 crore of net profit, with near-zero cumulative free cash flow and returns on equity far below any credible cost of capital. Other income has repeatedly been the difference between profit and loss. Management offers direction (pharma focus, value-added products, capacity enhancement) without numbers, timelines or funding plans, and it has not addressed the idle PVC assets or the long-pending BSE governance matter.
Q1 FY2027 is the most encouraging datapoint in three years: a 4.44% operating margin and INR 0.94 crore of quarterly profit show what modest volume growth can do to a low-fixed-cost converter. But Amco has produced isolated strong quarters before, and the market's round trip from INR ~63 to INR ~80 and back to INR ~67 shows that investors share that scepticism.
On balance, Amco is a deep-value, high-uncertainty micro-cap whose upside depends on sustaining Q1-type margins for several consecutive quarters while restoring cash generation. Until that is evidenced — and until governance overhangs are resolved — the book-value discount appears warranted rather than anomalous. Position sizing, if any, should reflect extreme illiquidity and the absence of independent coverage.
APPENDIX A — DATA DISCREPANCIES NOTED
| Item | Source A | Source B | Treatment |
|---|---|---|---|
| FY2026 aluminium foil revenue | MD&A: INR 11,013.62 lakh | Quarterly segment filings: foil = 100% of revenue from operations (~INR 11,776 lakh) | Both shown; difference labelled "reconciling difference" |
| Noida foil capacity | Website infrastructure page: 4,800 MTPA | Website products page: 2,400 MT foil p.a. | Both shown; unresolved |
| FY2026 operating margin | Screener annual row: 1.7% | Screener quarterly sum: 1.0% (reconciles to audited PBT) | Quarterly-reconciled figure used |
| Employees | FY2026 MD&A: 79 | Simply Wall St (S&P): 72 | Company figure used as latest |
| CMD compensation | FY2026 Directors' Report: INR 85.31 lakh | Simply Wall St: INR 6.05 million (likely FY2025) | Company figure used for FY2026 |
| Largest shareholder | MarketsMojo: Surender Kumar Gupta 17.94% | Simply Wall St top list omits him; shows Rajeev Gupta 16.03% | Both listed; reconciles to 65.55% promoter total |
| Q1 FY2027 EPS | Company: INR 2.30 | Screener: INR 2.29 | Rounding |
| Q1 FY2024 revenue | Screener: INR 29.50 crore | INDmoney: INR 29.80 crore | Screener used |
| CFO role | MarketScreener: Rhea Gupta CFO since 2018 | Simply Wall St: Rajeev Gupta was CFO until a recent date; Emkay lists four directors excluding Rhea Gupta | — |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Tenure / appointment | Background, education, age | FY2026 remuneration |
|---|---|---|---|---|
Rajeev (Kumar) Gupta (DIN 00025410) | Chairman & Managing Director; Audit Committee member | Whole-Time Director since 27 Aug 1987; CMD since 21 Jun 2024; previously also CFO (S&P data) | Promoter; ~39 years with the company. Education and age: not publicly disclosed in sources accessed | Salary INR 60.00 lakh + perquisites INR 25.31 lakh = INR 85.31 lakh (fixed INR 5 lakh/month; no performance-linked pay; no stock options; 1-month notice) |
Vidhu Gupta (DIN 00026934) | Director (promoter group); NRC member | Long-standing (date not disclosed) | Promoter family; holds 4.21% | Not disclosed separately |
Prarthana Gupta | Independent Director; Chair of Nomination & Remuneration Committee; Audit Committee member | Appointed 21 Jun 2024 (ratified at 37th AGM) | — | No sitting fees paid |
Naseem Ahmad | Independent Director; Chair of Audit Committee; NRC member | Date not disclosed | — | No sitting fees paid |
Neeraj Gupta | Additional Director (Independent, Non-Executive) | From 27 Aug 2026; subject to approval at 39th AGM | — | — |
Rhea Gupta | Director of Finance / CFO (per MarketScreener from 13 Sep 2018) | — | Graduate degrees from University College London and Jesus & Mary College (Delhi) per MarketScreener; holds 1.22% | — |
Company Secretary & Compliance Officer | KMP | ~4.8 years tenure (S&P data) | — | ~INR 43,600 (as reported by Simply Wall St; period/basis unclear) |
“—” = not publicly disclosed.
Directors' Remuneration
| Attribute | FY2026 position |
|---|---|
Board size | 4 through FY2026; 5 after 27 Aug 2026 |
Independence | 2 of 4 independent (50%); 3 of 5 after Neeraj Gupta's appointment (60%) |
Chair / CEO separation | No — combined Chairman & Managing Director (promoter) |
Women directors | 2 (Vidhu Gupta, Prarthana Gupta) |
Board meetings | 6 in FY2026 |
Committees | Audit (Naseem Ahmad – Chair; Prarthana Gupta; Rajeev Gupta); Nomination & Remuneration (Prarthana Gupta – Chair; Naseem Ahmad; Vidhu Gupta); Stakeholders Relationship; Internal Complaints Committees (Baddi, Noida) |
Separate ID meeting | 16 Mar 2026 |
Independent director compensation | No sitting fees; IDs hold no shares |
Board changes FY2026 | None; KMP changes: none |
Policies | Whistle-blower, NRC, RPT materiality, risk management, insider trading code — hosted on website |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
21 Jun 2024 | Rajeev Gupta elevated from Whole-Time Director to Chairman & MD | Approved at 37th AGM |
21 Jun 2024 | Prarthana Gupta appointed Independent Director | Approved at 37th AGM |
27 Aug 2026 | Neeraj Gupta appointed Additional Independent Director | For approval at 39th AGM (30 Sep 2026) |
Shareholding Pattern
| Category (%) | Jun 2024 | Jun 2025 | Jun 2026 |
|---|---|---|---|
Promoters & promoter group | 65.55 | 65.55 | 65.55 |
Government (PICUP) | 2.43 | 2.43 | 2.43 |
Public / non-institutional | 32.01 | 32.02 | 32.03 |
Number of shareholders | 2,887 | 3,067 | 3,032 |
Major Shareholders
| Holder | Category | Shares | Stake (%) | Source / date |
|---|---|---|---|---|
Surender Kumar Gupta | Promoter | ~737,300 (derived) | 17.94 | MarketsMojo, Jun 2026 |
Rajeev Gupta | Promoter (CMD) | 658,750 | 16.03 | Simply Wall St (S&P), 2025 |
Vijay Laxmi Gupta | Promoter | 399,300 | 9.72 | Simply Wall St |
AMC Coated Fabrics Pvt Ltd | Promoter group (corporate) | 396,175 | 9.64 | Simply Wall St |
Raju Ajit Bhandari | Public | 220,962 | 5.38 | Simply Wall St; MarketsMojo |
Poonam Gupta | Promoter | 175,100 | 4.26 | Simply Wall St |
Vidhu Gupta | Promoter (Director) | 173,053 | 4.21 | Simply Wall St |
S. Sangeetha | Public | 149,125 | 3.63 | Simply Wall St |
Pradeshiya Industrial & Investment Corporation of UP (PICUP) | Government/DII | 100,000 | 2.43 | Simply Wall St; BSE |
Hitesh Javeri | Public | 70,200 | 1.71 | Simply Wall St |
Harsha Javeri | Public | 70,000 | 1.70 | Simply Wall St |
Rupashi Gupta | Promoter | 50,000 | 1.22 | Simply Wall St |
Rhea Gupta | Promoter | 50,000 | 1.22 | Simply Wall St |
Surender Kumar Gupta HUF | Promoter | ~54,000 (derived) | ~1.31 (derived residual) | Derived from 65.55% total |
Competitive Landscape
Key Competitors
| # | Competitor | Segment overlap | Scale / revenue | Relative positioning vs Amco |
|---|---|---|---|---|
| 1 | Hindalco Industries (incl. foil & packaging business) | Aluminium foil (integrated from bauxite to foil) | Consolidated revenue > INR 2 lakh crore (FY2025, approx.) | Dominant integrated player; metal security and scale Amco cannot match |
| 2 | Jindal (India) Ltd / Jindal Aluminium group foil units | Aluminium foil | — | Larger rolling capacity; competes in plain and converted foil |
| 3 | Raviraj Foils Ltd | Aluminium foil, pharma and packaging | — | Listed small-cap peer; direct overlap in pharma foil |
| 4 | Uflex Ltd | Flexible packaging incl. pharma laminates | — | Integrated films + converting; captures laminate value Amco sells into |
| 5 | Bilcare Ltd | Pharma packaging films/foils | — | Specialist pharma packaging; R&D-led |
| 6 | ACG (Associated Capsules Group) — ACG Pharmapack (unlisted) | Pharma blister films and foils | — | Global-scale pharma packaging specialist |
| 7 | Constantia Flexibles (India operations) / Amcor (India) | Pharma & food flexible packaging incl. foil laminates | — | Multinational converters with global pharma accounts |
| 8 | Sacheta Metals Ltd | Aluminium foil containers/foil products | — | Listed micro-cap peer named by Business Standard |
| 9 | Sudal Industries Ltd | Aluminium products (extrusions) | — | Listed micro-cap aluminium peer (BS peer list); limited direct overlap |
| 10 | Essen Speciality Films Ltd | PVC/plastic films & sheets | — | Listed peer for the dormant PVC segment (Emkay peer list) |
| 11 | Chinese foil imports | Plain and converted foil | — | Price-setting competition flagged by MD&A (for PVC explicitly; foil exposure implied) |
| 12 | Unorganised/regional converters (Baddi, Daman, Ahmedabad clusters) | Pharma printed foil | — | Fragmented, price-competitive; same customer base |
Peer Comparison FY2026
| Metric | Amco India | Hindalco (integrated leader) |
|---|---|---|
Revenue (latest FY) | INR 117.8 cr (FY2026) |
|
Revenue growth | +11.8% (FY2026) | — |
Operating margin | 1.0% (FY2026) | — |
R&D intensity | 0% | Not disclosed here |
Exports | Nil (FY2026) | Large |
Recent Developments
*Pending: Q2 FY2027 results (quarter ended 30 Sep 2026) due by mid-November 2026 under LODR timelines; board-meeting date not yet verified.



